Comprehensive Arrhythmia and Cardiomyopathy Panel
Use
This test is for individuals with relevant features who have a clinical or suspected diagnosis of cardiac arrhythmia and/or cardiomyopathy. It is also for individuals with unexplained sudden cardiac death/arrest and individuals with a family history suggestive of cardiac arrhythmia and/or cardiomyopathy.
Special Instructions
The test is offered on both Exome and Genome platforms, and can be ordered with additional options like Exome-Wide CNV Analysis or STAT Testing. Orders can be placed online through myPrevent, or by fax using the Test Requisition Form available for download.
Limitations
The tests have not been cleared or approved by the US Food and Drug Administration. The performance characteristics of the tests were validated by PreventionGenetics LLC under CAP and CLIA regulations, but specific limitations or sensitivity parameters are not provided.
New York Approved
Methodology
NGS (CGP)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided